Form 4: Intellia Therapeutics CFO Sells Shares
Insider Transaction (Form 4)
Edward J Dulac Iii, EVP, Chief Financial Officer of Intellia Therapeutics, Inc., sold 8,111 shares of common stock on July 22, 2026 for $11.25 per share.
Summary
- Open-market sale: disposed of 8,111 Common Stock at $11.25 ($91,249) on July 22, 2026; holds 148,175 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $91,249 of stock on the open market.
Insider Transactions
Edward J Dulac Iii — Officer (EVP, Chief Financial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-22 | Open-market sale | Common Stock | 8,111 | $11 | $91.2K | 148,175 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-22 | Open-market sale (8,111 shares) |
Keywords
insider transaction, Form 4, NTLA, Intellia Therapeutics, Inc., bearish, Edward J Dulac Iii
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.